» Articles » PMID: 31540192

Key Topics in Molecular Docking for Drug Design

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Sep 22
PMID 31540192
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular docking has been widely employed as a fast and inexpensive technique in the past decades, both in academic and industrial settings. Although this discipline has now had enough time to consolidate, many aspects remain challenging and there is still not a straightforward and accurate route to readily pinpoint true ligands among a set of molecules, nor to identify with precision the correct ligand conformation within the binding pocket of a given target molecule. Nevertheless, new approaches continue to be developed and the volume of published works grows at a rapid pace. In this review, we present an overview of the method and attempt to summarise recent developments regarding four main aspects of molecular docking approaches: (i) the available benchmarking sets, highlighting their advantages and caveats, (ii) the advances in consensus methods, (iii) recent algorithms and applications using fragment-based approaches, and (iv) the use of machine learning algorithms in molecular docking. These recent developments incrementally contribute to an increase in accuracy and are expected, given time, and together with advances in computing power and hardware capability, to eventually accomplish the full potential of this area.

Citing Articles

Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study.

Koksal Z, Senol H Arch Pharm (Weinheim). 2025; 358(3):e2400909.

PMID: 40071685 PMC: 11898576. DOI: 10.1002/ardp.202400909.


Neuroprotective efficacy of berberine and caffeine against rotenone-induced neuroinflammatory and oxidative disturbances associated with Parkinson's disease via inhibiting α-synuclein aggregation and boosting dopamine release.

Waheeb T, Abdulkader M, Ghareeb D, Moustafa M Inflammopharmacology. 2025; .

PMID: 40057928 DOI: 10.1007/s10787-025-01661-w.


QSAR, Antimicrobial, and Antiproliferative Study of (/)-2-Thioxo-3,4-dihydropyrimidine-5-carboxanilides.

Parmar M, Das A, Vala D, Bhalodiya S, Patel C, Balachandran S ACS Omega. 2025; 10(7):7013-7026.

PMID: 40028097 PMC: 11866182. DOI: 10.1021/acsomega.4c09899.


Approaches for Inclusion Complexes of Ezetimibe with Cyclodextrins: Strategies for Solubility Enhancement and Interaction Analysis via Molecular Docking.

Cho D, Lee J, Kim M, Cho H, Cho J, Kim K Int J Mol Sci. 2025; 26(4).

PMID: 40004150 PMC: 11855275. DOI: 10.3390/ijms26041686.


Dynamic Visualization of Computer-Aided Peptide Design for Cancer Therapeutics.

Hou D, Zhou H, Tang Y, Liu Z, Su L, Guo J Drug Des Devel Ther. 2025; 19:1043-1065.

PMID: 39974609 PMC: 11837852. DOI: 10.2147/DDDT.S497126.


References
1.
Yuriev E, Ramsland P . Latest developments in molecular docking: 2010-2011 in review. J Mol Recognit. 2013; 26(5):215-39. DOI: 10.1002/jmr.2266. View

2.
Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

3.
Wang L, Pang X, Li Y, Zhang Z, Tan W . RADER: a RApid DEcoy Retriever to facilitate decoy based assessment of virtual screening. Bioinformatics. 2016; 33(8):1235-1237. DOI: 10.1093/bioinformatics/btw783. View

4.
Darras F, Pockes S, Huang G, Wehle S, Strasser A, Wittmann H . Synthesis, biological evaluation, and computational studies of Tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists. ACS Chem Neurosci. 2014; 5(3):225-42. PMC: 3963125. DOI: 10.1021/cn4002126. View

5.
Kundu I, Paul G, Banerjee R . A machine learning approach towards the prediction of protein-ligand binding affinity based on fundamental molecular properties. RSC Adv. 2022; 8(22):12127-12137. PMC: 9079328. DOI: 10.1039/c8ra00003d. View